Epidermal growth factor receptor mutations have been detected in 2–17% of NSCLC patients from Europe and the United States, however, the mutational frequency increases to 30% when analyzing cases from East Asia (73–75). This evidence concerns the gene EGFR and non-small cell lung carcinoma.